Dolby Investor Relations

SAN FRANCISCO--(BUSINESS WIRE)-- Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for the fourth quarter and fiscal year ended September 30, 2011.

For the fourth quarter, Dolby reported total revenue of $243.8 million, compared to $227.8 million for the fourth quarter of fiscal 2010.

Fourth quarter GAAP net income was $79.1 million, or $0.71 per diluted share, compared to $65.0 million, or $0.57 per diluted share, for the fourth quarter of fiscal 2010. On a non-GAAP basis, fourth quarter net income was $89.9 million, or $0.81 per diluted share, compared to $74.9 million, or $0.66 per diluted share, for the fourth quarter of fiscal 2010.

Fiscal year GAAP net income was $309.3 million, or $2.75 per diluted share, compared to $283.4 million, or $2.46 per diluted share, for fiscal year 2010. On a non-GAAP basis, fiscal year net income was $339.9 million, or $3.02 per diluted share, compared to $313.5 million, or $2.72 per diluted share for fiscal 2010. Dolby's non-GAAP measures exclude expenses related to stock-based compensation, the amortization of intangibles from business combinations, restructuring charges, and the related tax impact of these items. The non-GAAP measures also exclude the one-time tax benefit resulting from the release of a deferred tax liability in the first quarter of fiscal 2011.

"We continued to see solid growth from our broadcast market in the fourth quarter, helping licensing revenue finish up 11 percent for the fiscal year," said Kevin Yeaman, President and Chief Executive Officer, Dolby Laboratories. "We continue to see a significant opportunity in broadcast and remain focused on extending our technologies to online content and a growing array of portable devices."

Financial Targets

For fiscal 2012, Dolby is targeting revenue of $910 million to $970 million.

GAAP

For fiscal 2012, Dolby is targeting total gross margin of approximately 90 percent, operating expenses of $465 million to $475 million, and other income of approximately $5 million. In addition, Dolby is targeting a tax rate of approximately 29 percent to 30 percent for fiscal 2012. While stock-based compensation expense may vary based on factors such as stock price or volatility, Dolby is targeting stock-based compensation expense for fiscal 2012 of approximately $51 million. In addition, Dolby is targeting charges related to the amortization of acquired intangibles for fiscal 2012 of approximately $10 million and restructuring charges of approximately $2 million.

Non-GAAP

For fiscal 2012, Dolby is targeting total gross margin of approximately 91 percent, operating expenses of $410 million to $420 million, and other income of approximately $5 million. In addition, Dolby is targeting a tax rate of approximately 29 percent to 30 percent for fiscal 2012. Dolby's non-GAAP targets exclude expenses related to stock-based compensation, the amortization of intangibles from business combinations, restructuring charges, and the related tax impact of these items.

Diluted Earnings Per Share

Dolby is targeting diluted shares outstanding of approximately 110 million. These targets lead to fiscal 2012 diluted earnings per share target range of $2.31 to $2.61 on a GAAP basis and $2.71 to $3.02 on a non-GAAP basis.

The Company's Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss Dolby Laboratories' Q4 and year-end fiscal 2011 financial results at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, November 17, 2011.

Access to the teleconference will be available over the Internet from http://investor.dolby.com/medialist.cfm or by dialing 1-888-329-8903 from within the United States or 1-719-457-2731 from outside the country.

A replay of the call will be available from 5:00 p.m. PT on Thursday, November 17, 2011, until 9:00 p.m. PT on Thursday, November 24, 2011. Callers can dial 1-877-870-5176 from within the United States or 1-858-384-5517 from outside the US, then enter the confirmation code 4184766. An archived version of the teleconference will also be available on the Dolby Laboratories website, www.dolby.com.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides non-GAAP financial measures of gross margin, operating expense, tax rate, and diluted earnings per share. These measures are adjusted to exclude the charges and expenses discussed above. Dolby presents such non-GAAP financial measures in reporting its financial results to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Dolby's management believes it is useful for itself and investors to review, as applicable, both GAAP information that includes the impact of stock-based compensation expense, amortization of intangible assets acquired through business combinations, restructuring charges, and the related tax impact of all of these items on the provision for income taxes, and the non-GAAP measures that exclude such information in order to assess the performance of Dolby's business for planning and forecasting in subsequent periods. Dolby's management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses such a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its SEC filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on our investor relations website at http://investor.dolby.com/medialist.cfm.

Forward-Looking Statements

Certain statements in this press release, including statements relating to Dolby's expectations regarding revenue, gross margin, operating expense, other income, tax rate, stock-based compensation, amortization of intangibles, restructuring charges, and diluted earnings per share for fiscal 2012, and its statements regarding continued broadcast growth opportunities, and extending its technologies to online content and a growing array of portable devices, and the benefits that may be derived from them are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks that Dolby technologies may not be included in future PC operating systems; risks associated with trends in the markets in which Dolby operates, including the personal computer, DVD, and Blu-ray Disc™, broadcast, consumer electronics, gaming, mobile, and automobile markets; pricing pressures; risks that shifts from disc-based media to online media content could result in fewer devices with Dolby technologies; risks associated with the effects of macroeconomic conditions; the timing of Dolby's receipt of royalty reports and/or payments from its licensees; Dolby's accuracy of calculation of royalties due to its licensors; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets in the entertainment industry; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; the development and growth of the market for digital cinema and digital 3D and Dolby's ability to successfully penetrate this market; Dolby's ability to expand its business generally, and to expand its business beyond sound technologies to other technologies related to digital entertainment delivery, by acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's Securities and Exchange Commission filings and reports, including the risks identified under the section captioned "Risk Factors" in its most recent quarterly report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE:DLB) is the global leader in technologies that are essential elements in the best entertainment experiences. Founded in 1965 and best known for high-quality audio and surround sound, Dolby creates innovations that enrich entertainment at the movies, at home, or on the go. For more information about Dolby Laboratories or Dolby^® technologies, please visit www.dolby.com.

Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. Blu-ray Disc is a trademark of Blu-ray Disc Association. S11/25076 DLB-F

DOLBY LABORATORIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
		Fiscal Quarter Ended										Fiscal Year Ended
		September 24, 2010					September 30, 2011					September 24, 2010					September 30, 2011
		(in thousands, except per share amounts)
Revenue:
Licensing		$	178,429				$	205,747				$	710,474				$	790,340
Products			40,255					30,842					180,402					131,611
Services			9,123					7,179					31,837					33,554
Total revenue			227,807					243,768					922,713					955,505
Cost of revenue:
Cost of licensing			4,283					3,793					17,565					17,620
Cost of products (1)			18,653					18,779					90,695					81,328
Cost of services (1)			3,407					3,070					13,961					12,223
Impairment of products provided under operating leases			-					-					9,594					-
Total cost of revenue			26,343					25,642					131,815					111,171
Gross margin			201,464					218,126					790,898					844,334
Operating expenses:
Research and development (1)			29,417					33,108					104,978					123,920
Sales and marketing (1)			36,525					37,154					130,160					149,642
General and administrative (1)			32,676					33,039					119,353					137,633
Restructuring charges, net			5,655					2,669					7,026					3,406
Total operating expenses			104,273					105,970					361,517					414,601
Operating income			97,191					112,156					429,381					429,733
Other income, net			1,431					4,476					7,631					10,910
Income before provision for income taxes			98,622					116,632					437,012					440,643
Provision for income taxes			(35,295	)				(37,344	)				(154,185	)				(130,061	)
Net income including controlling interest			63,327					79,288					282,827					310,582
Less: net (income) / loss attributable to controlling interest			1,684					(217	)				620					(1,315	)
Net income attributable to Dolby Laboratories, Inc.		$	65,011				$	79,071				$	283,447				$	309,267
Basic earnings per share		$	0.58				$	0.72				$	2.50				$	2.78
Diluted earnings per share		$	0.57				$	0.71				$	2.46				$	2.75
Weighted-average shares outstanding (basic)			112,486					110,063					113,452					111,444
Weighted-average shares outstanding (diluted)			114,276					110,662					115,388					112,554
(1) Stock-based compensation included above was classified as follows:
Cost of products		$	115				$	159				$	427				$	642
Cost of services			34					53					126					182
Research and development			1,922					2,591					6,535					10,157
Sales and marketing			2,321					3,392					8,843					13,184
General and administrative			3,408					4,554					12,884					19,500

DOLBY LABORATORIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
		September 24, 2010				September 30, 2011
		(unaudited)
		(in thousands)
ASSETS
Current assets:
Cash and cash equivalents		$	545,861			$	551,512
Short-term investments			302,269				391,281
Accounts receivable, net			54,257				61,815
Inventories			28,338				26,244
Deferred taxes			102,758				90,869
Prepaid expenses and other current assets			26,930				36,877
Total current assets			1,060,413				1,158,598
Long-term investments			190,837				272,797
Property, plant and equipment, net			94,097				117,107
Intangible assets, net			67,019				51,573
Goodwill			264,580				263,260
Deferred taxes			19,948				14,779
Other non-current assets			14,878				6,273
Total assets		$	1,711,772			$	1,884,387
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued liabilities		$	148,214			$	127,922
Income taxes payable			7,895				4,762
Deferred revenue			9,647				26,701
Total current liabilities			165,756				159,385
Long-term deferred revenue			12,775				15,526
Deferred taxes			11,547				671
Other non-current liabilities			27,015				23,455
Total liabilities			217,093				199,037
Stockholders' equity:
Class A common stock			53				52
Class B common stock			59				58
Additional paid-in capital			329,902				210,681
Retained earnings			1,135,922				1,445,189
Accumulated other comprehensive income			7,801				7,533
Total stockholders' equity - Dolby Laboratories, Inc.			1,473,737				1,663,513
Controlling interest			20,942				21,837
Total stockholders' equity			1,494,679				1,685,350
Total liabilities and stockholders' equity		$	1,711,772			$	1,884,387

DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
		Fiscal Quarter Ended										Fiscal Year Ended
		September 24, 2010					September 30, 2011					September 24, 2010					September 30, 2011
		(unaudited)
		(in thousands)
Operating activities:
Net income including controlling interest		$	63,327				$	79,288				$	282,827				$	310,582
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			9,392					10,019					34,937					43,994
Stock-based compensation expense			7,800					10,749					28,815					43,665
Amortization of premium on investments			2,734					4,713					9,118					17,088
Excess tax benefit from exercise of stock options			(7,749	)				6,050					(24,639	)				(6,593	)
Provision for doubtful accounts			546					(56	)				365					772
Deferred taxes			5,751					5,211					(16,031	)				6,784
Losses / (gains) on Put Rights			1,095					-					7,601					-
Losses / (gains) on auction rate certificates			-					-					(7,601	)				-
Loss on impairment of long-lived assets			3,392					226					12,986					226
Payment on litigation settlement			-					-					(3,000	)				(3,000	)
Other non-cash items affecting net income			(1,660	)				357					347					532
Changes in operating assets and liabilities:
Accounts receivable			(6,734	)				(22,579	)				(31,329	)				(8,514	)
Inventories			(11,609	)				(2,822	)				(15,696	)				2,105
Prepaid expenses and other assets			(721	)				(3,587	)				15,009					(10,305	)
Accounts payable and accrued liabilities			7,797					10,837					31,556					(16,952	)
Income taxes, net			(3,908	)				(5,678	)				27,995					708
Deferred revenue			(1,443	)				14,400					(25,725	)				19,800
Other non-current liabilities			(163	)				2,401					(237	)				2,796
Net cash provided by operating activities			67,847					109,529					327,298					403,688
Investing activities:
Purchases of available-for-sale securities			(89,880	)				(164,443	)				(646,052	)				(619,238	)
Proceeds from sale of available-for-sale and trading securities			123,586					84,062					643,443					429,681
Purchases of property, plant and equipment			(12,429	)				(17,028	)				(37,482	)				(47,362	)
Acquisitions, net of cash acquired			(5,601	)				-					(5,601	)				(3,350	)
Purchases of intangible assets			-					-					(825	)				-
Proceeds from sale of property, plant and equipment			1,989					490					2,160					3,567
Net cash provided by/(used in) investing activities			17,665					(96,919	)				(44,357	)				(236,702	)
Financing activities:
Payments on debt			(6,488	)				-					(7,680	)				-
Proceeds from issuance of Class A common stock (Employee Stock Purchase Plan)			-					13					4,060					5,442
Proceeds from exercise of stock options			2,621					386					35,569					17,877
Repurchase of common stock			(63,714	)				(49,910	)				(241,362	)				(192,410	)
Excess tax benefit from exercise of stock options			7,749					(6,050	)				24,639					6,593
Net cash used in financing activities			(59,832	)				(55,561	)				(184,774	)				(162,498	)
Effect of foreign exchange rate changes on cash and cash equivalents			1,083					(141	)				(3,984	)				1,163
Net increase in cash and cash equivalents			26,763					(43,092	)				94,183					5,651
Cash and cash equivalents at beginning of period			519,098					594,604					451,678					545,861
Cash and cash equivalents at end of period		$	545,861				$	551,512				$	545,861				$	551,512

GAAP to Non-GAAP Reconciliations
(In millions, except per share data)
The following tables show the Company's fourth quarter of fiscal 2011 and fiscal 2011 year-to-date GAAP financial measures reconciled to non-GAAP financial measures included in this release:
Net income:		Fiscal Quarter Ended				Fiscal Year Ended
		September 30, 2011				September 30, 2011
GAAP net income		$	79.1			$	309.3
Stock-based compensation			10.7				43.7
Amortization of acquired intangibles			2.7				15.2
Restructuring charges, net			2.7				3.4
Income tax adjustments			(5.3	)			(31.7	)
Non-GAAP net income			89.9				339.9
Diluted earnings per share:		Fiscal Quarter Ended				Fiscal Year Ended
		September 30, 2011				September 30, 2011
GAAP diluted earnings per share		$	0.71			$	2.75
Stock-based compensation			0.10				0.39
Amortization of acquired intangibles			0.02				0.13
Restructuring charges, net			0.03				0.03
Income tax adjustments			(0.05	)			(0.28	)
Non-GAAP diluted earnings per share		$	0.81			$	3.02
Shares used in computing diluted earnings per share			111				113
The following tables show the Company's fiscal year 2012 GAAP financial targets reconciled to non-GAAP financial targets included in this release (numbers are approximate):
Gross margin:
		Fiscal Year 2012
GAAP gross margin			90	%
Stock-based compensation			0	%
Amortization of acquired intangibles			1	%
Non-GAAP gross margin			91	%
Product gross margin:		Fiscal Year 2012
		Low				High
GAAP products gross margin			37	%			39	%
Stock-based compensation			1	%			1	%
Amortization of acquired intangibles			2	%			2	%
Non-GAAP products gross margin			40	%			42	%
Operating expenses:		Fiscal Year 2012
		Low				High
GAAP operating expenses		$	465			$	475
Stock-based compensation			(50	)			(50	)
Amortization of acquired intangibles			(3	)			(3	)
Restructuring charges, net			(2	)			(2	)
Non-GAAP operating expenses		$	410			$	420
Operating expense run-rate:
		Q4 2011 Exit Run-Rate
GAAP operating expense run-rate		$	115
Stock-based compensation			(12	)
Amortization of acquired intangibles			(1	)
Restructuring charges, net			(1	)
Non-GAAP operating expense run-rate		$	101
Diluted earnings per share:		Fiscal Year 2012
		Low				High
GAAP diluted earnings per share		$	2.31			$	2.61
Stock-based compensation			0.46				0.46
Amortization of acquired intangibles			0.09				0.09
Restructuring charges, net			0.02				0.02
Income tax adjustments			(0.17	)			(0.16	)
Non-GAAP diluted earnings per share		$	2.71			$	3.02
Shares used in computing diluted earnings per share			110				110

Dolby Laboratories
Investor Contact:
Alex Hughes, 415-645-4572
investor@dolby.com
Media Contact:
Sean Durkin, 415-645-5176
news@dolby.com

Source: Dolby Laboratories, Inc.

News Provided by Acquire Media